From: Feasibility of breast conservation after neoadjuvant taxene based chemotherapy in locally advanced breast cancer: a Prospective Phase I trial
Clinical Stage
N
Grade
HR
G II
G III
HR +
HR -
T3N0
10 (8)
8 (6)
2 (2)
9 (8)
1 (0)
T3N1
25 (20)
16 (12)
22 (17)
3 (3)
T3N2
6 (4)
4 (2)
3 (1)
T2N2
4 (4)
1 (1)
Total
45 (36)
30 (22)
15 (14)
37 (29)
8 (7)